Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1Other hematologic neoplasm 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 313Leukemia 119Lymphoma 108Lymphoma, Follicular 104Lymphoma, Non-Hodgkin 102Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Lymphoma, B-Cell, Marginal Zone 90Lymphoma, Mantle-Cell 78Lymphoma, Large B-Cell, Diffuse 67Burkitt Lymphoma 61Waldenstrom Macroglobulinemia 47Lymphoma, Large-Cell, Immunoblastic 38Hodgkin Disease 33Myelodysplastic Syndromes 24Leukemia, Myeloid, Acute 24Hematologic Neoplasms 22Leukemia, Hairy Cell 20Recurrence 19Multiple Myeloma 18Lymphoma, B-Cell 18Leukemia, Prolymphocytic 16Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Large-Cell, Anaplastic 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, B-Cell 11Intraocular Lymphoma 11Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Accelerated Phase 10Neoplasms, Plasma Cell 9Lymphoma, T-Cell, Cutaneous 9

Interventions

obinutuzumab 1acalabrutinib 1Standard of Care 1Rituximab 1Practice Guidelines as Topic 1Mesenchymal Stem Cell Transplantation 1Lenalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Heart Failure × Rituximab × Other hematologic neoplasm × Clear all
NCT06651970 2026-05-18

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

AstraZeneca

Phase 4 Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Heart Failure, Lymphatic Diseases, Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡